Delivery Order SPE2DB24D2109-SPE2DB25FHXUJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors valued at $12,590.49. This non-competitive, firm fixed-price delivery order is expected to be completed by August 19, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,878.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 19, 2025, with completion scheduled for August 20, 2025. This competitive award, with no set-aside designation, represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The...
- The Defense Logistics Agency awarded a $1,986.80 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order for pharmaceutical supply to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $2,027.10 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL). This firm fixed-price, non-set-aside contract will be fulfilled from the vendor's Conshohocken, Pennsylvania location, with an ultimate completion date of August 15, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Trulicity 4.5 mg/0.5 ml pen injectors with a firm fixed price ceiling value of $2,644.53 and an ultimate completion date of July 22, 2025. This is a non-set-aside competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vehicle running through December 2026 that supports global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a ceiling value of $3,156.24. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery...
- The Defense Logistics Agency awarded a $2,553.60 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors with a 0.5 mL dosage. The contract utilizes a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be completed by August 21, 2025, at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,702.10 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen injectors on August 19, 2025, with completion expected by August 20, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was processed through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors, valued at $7,285.49 under a firm fixed price contract. This non-competitive delivery order, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal healthcare systems,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $7,798.34 with a completion date of August 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's broader pharmaceutical supply contract portfolio. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- SPE2DB24D2109Indefinite Delivery Contract
- SPE2DB24D2109-SPE2DB25FHXUJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $1,801.80. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is scheduled for ultimate completion on August 29, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order for Trulicity, a diabetes medication, exemplifies the company's role supplying brand-name and generic pharmaceuticals across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. The award reflects AmerisourceBergen's established capability to fulfill federal medical supply requirements through its extensive portfolio of competitively awarded contracts with the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/28/25 |